Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

INTRA-CELLULAR THERAPIES, INC.

Filed by DLA PIPER LLP (US).

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-24 06:26:08 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Termination
Posted
Jan 16, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
eaa4a4fc-ed4d-40eb-8860-6f0201135bc8
Termination date
Dec 31, 2025

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health. H.R. 5376, Impacts and Outcomes for Health Career Training Act.

Literal federal measure citations: H.R. 5376

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.